An evidence-based management tool embedded within electronic health records of patients with headache in a northern New ...

### Philosophy of the guideline ### Assessing patients Figure 1 Chart 1: Oxygen prescription for acutely hypoxaemic patients in hospital. ABG, arterial blood gas; COPD, chronic obstructive pulmonary ...

Objectives Consultation duration has previously been shown to be associated with patient, practitioner and practice characteristics. However, previous studies were conducted outside the UK, considered ...

Errors in the process can lead to serious harm for patients,1, 3–6 and medicolegal concerns for healthcare providers.7–9 General practices in the UK recently identified the handling of test results as ...

This work presents a case study of process development using continuous flow synthesis. In developing a process for manufacturing drug substances in batch reactors, we unexpectedly obtained a ...

Objectives To quantify the duration of each step of the diagnostic pathway for patients with multiple myeloma from symptom onset to confirmation of diagnosis. Design Systematic review and ...

The Swiss government has approved the text of a proposed new treaty with the European Union and sent it out for consultation by the end of October. This content was published on June 13, 2025 - 16:19 ...

Industrial companies Chart Industries Inc. and Flowserve Corp. agreed to merge in a deal valuing the combined company at about $19 billion. Chart shareholders will receive 3.165 shares of ...

Chart Industries, Inc. is a global leader in the design, engineering, and manufacturing of process technologies and equipment for gas and liquid molecule handling for the Nexus of Clean™ - clean ...

NodThera Charts Obesity Future with First Patients Dosed in Phase 2 RESOLVE-1 Trial of Oral NLRP3 Inflammasome Inhibitor NT-0796 Provided by GlobeNewswire Jun 4, 2025, 11:00:00 AM ...

RESOLVE-1 is a randomized, double-blind, placebo-controlled Phase 2 trial that will evaluate the efficacy and safety of NT-0796 in patients with obesity, with or without type 2 diabetes, over 24 weeks ...